Abstract
Further improvement of chemotherapy for acute myeloid leukemia (AML) requires an evaluation of alternative treatment strategies as investigated in adequate prospective multicenter trials. Since no superior new drugs are available, treatment can be improved only by finding superior treatment strategies and combining them successfully, if possible. The major treatment strategies to be discussed here are
-
a)
long-term cylic myelosuppressive chemotherapy concepts (maintenance) and
-
b)
intensified postremission or preremission chemotherapy concepts (intensification).
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsPreview
Unable to display preview. Download preview PDF.
References
Büchner T, Urbanitz D, Hiddemann W et al. (1985) Intensified induction and consolidation with or without maintenance chemotherapy for acute myeloid leukemia (AML): two multicenter studies of the German AML Cooperative Group. J Clin Oncol 3: 1583
Büchner T, Hiddemann W, Wendt F et al. (1987) Early intensification by double induction (DI) in adult AML: a multicenter study of the AML Cooperative Group. Blood 70 [Suppl 1]: 752
Hiddemann W, Kreutzmann H, Straif K et al. (1987) High-dose cytosine arabinoside and mitoxantrone (HAM): a highly effective regimen in refractory acute myeloid leukemia. Blood 69: 744
Rai KR, Holland JF, Glidewell OJ et al. (1981) Treatment of acute myelocytic leukemia: a study by Cancer and Leukemia Group B. Blood 58: 1203
Yates J, Glidewell O, Wiernik P et al. (1982) Cytosine arabinoside with daunorubicin or adriamycin for therapy of acute myelocytic leukemia. A CALGB study. Blood 60: 454
Sauter C, Fopp M, Imbach P et al. (1984) Acute myelogenous leukaemia. Maintenance chemotherapy after early consolidation treatment does not prolong survival. Lancet i: 379
Vogler WR, Winton EF, Gordon DS et al. (1984) A randomized comparison of postremission therapy in acute myelogenous leukemia: a Southeast Cancer Study Group trial. Blood 63: 1039
Cassileth PA, Begg CB, Bennett JM et al. (1984) A randomized study of the efficacy of consolidation therapy in adult acute nonlymphocytic leukemia. Blood 63: 843
Hayat M, Jehn U, Willemze R et al. (1986) A randomized comparison of maintenance treatment with androgens, immunotherapy, and chemotherapy in adult acute myelogenous leukemia. A Leukemia-Lymphoma Group trial of the EORTC. Cancer 58: 617
Rees JKH, Swirsky D, Gray RG, Hayhoe FGJ (1986) Principal results of the Medical Research Council’s 8th acute myeloid leukaemia trial. Lancet ii: 1236
Preisler H, Davis RB, Kirshner J et al. (1987) Comparison of three remission induction regimens and two postinduction strategies for the treatment of acute nonlymphocytic leukemia: a Cancer and Leukemia Group B study. Blood 69: 1441
Cassileth PA, Harrington DP, Hines JD et al. (1988) Maintenance chemotherapy prolongs remission duration in adult nonlymphocytic leukemia. J Clin Oncol 6: 583
Wolff SN, Herzig RH, Phillips GL et al. (1987) High-dose cytosine arabinoside and daunorubicin as consolidation therapy for acute nonlymphocytic leukemia in first remission: an update. Semin Oncol 14 [Suppl 1]: 12
Preisler HD, Raza A, Early A et al. (1987) Intensive remission consolidation therapy in the treatment of acute nonlymphocytic leukemia. J Clin Oncol 5: 722
Mayer RJ, Schiffer CA, Peterson BA et al. (1987) Intensive postremission therapy in adults with acute nonlymphocytic leukemia using various dose schedules of ara-C: a progress report from the CALGB. Semin Oncol 14: [Suppl 1]: 25
Kurrle E, Ehninger G, Fackler-Schwalbe E et al. (1989) Consolidation therapy with highdose cytosine arabinoside. Experiences of a prospective study in acute myeloid leukaemia. In: Büchner T, Schellong G, Hiddemann W, Ritter J (eds) Acute leukemias II - prognostic factors and treatment strategies. Springer, Berlin Heidelberg New York
Büchner T, Hiddemann W, Koenigsmann M et al. (1989) Chemotherapy (CT) followed by recombinant human granulocyte macrophage colony stimulating factor ( GM-CSF) for acute leukemias at higher age or after relapse. Proc Am Assoc Cancer Res Am Soc Clin Oncol 8: 770
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1990 Springer-Verlag Berlin Heidelberg
About this paper
Cite this paper
Büchner, T. et al. (1990). Adult AML: The Role of Chemotherapy Intensity and Duration. Two Studies of the AML Cooperative Group. In: Büchner, T., Schellong, G., Hiddemann, W., Ritter, J. (eds) Acute Leukemias II. Haematology and Blood Transfusion / Hämatologie und Bluttransfusion, vol 33. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-74643-7_47
Download citation
DOI: https://doi.org/10.1007/978-3-642-74643-7_47
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-540-50984-4
Online ISBN: 978-3-642-74643-7
eBook Packages: Springer Book Archive